3-month daily rifampicin and isoniazid compared to 6- or 9-month isoniazid for treating latent tuberculosis infection in children and adolescents less than 15 years of age: an updated systematic review

Treatment of latent tuberculosis infection in children with a 3-month daily rifampicin and isoniazid regimen is safe with better compliance, adherence and completion rate than a 6- or 9-month isoniazid monotherapy http://ow.ly/x28Z30jDfCE

Detalles Bibliográficos
Autores principales: Assefa, Yibeltal, Assefa, Yalemzewod, Woldeyohannes, Solomon, Hamada, Yohhei, Getahun, Haileyesus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2018
Materias:
Agora
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095703/
https://www.ncbi.nlm.nih.gov/pubmed/29748305
http://dx.doi.org/10.1183/13993003.00395-2018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6095703/
https://www.ncbi.nlm.nih.gov/pubmed/29748305
http://dx.doi.org/10.1183/13993003.00395-2018

Ejemplares similares